Alan Rossi Silva
Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug
The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma
29 years without Jonas Salk: against the normalization of the absurd
Nearly three decades after Jonas Salk’s passing, his legacy continues to highlight the need for building a different pharmaceutical industry
Pharma companies attempt to overturn Brazilian Supreme Court’s historic decision on patents
Felipe Carvalho Borges da Fonseca
Susana Rodrigues Cavalcanti Van Der Ploeg
Maria Clara Pfeiffer Noronha
Alan Rossi Silva
/
December 15, 2022
Pharmaceutical companies are trying to undermine a decision of the Brazilian Supreme Court from 2021 which puts health ahead of private profit
Access to medicines summit urges for more decisive action against Big Pharma domination
Activists and academics discussed future of the access to medicines movement at the Global Summit on Intellectual Property and Access to Medicines in Istanbul at the end of July
- ILA dock workers reach tentative agreement
- Israel suffers losses in ground battles in Lebanon and insists on escalating to regional war
- Claudia Sheinbaum sworn in as president of Mexico
- US threatens “severe consequences” for Iran
- Trade unions demand respect of rights as PM Barnier announces more austerity
